Insulin-mediated pseudoacromegaly (IMPA) represents a distinct biochemical and physical phenotype when compared with other insulin resistance syndromes due to extreme postprandial insulin resistance, severe acanthosis nigricans, and hyperandrogenism in the setting of extreme tall stature, obesity, and overgrowth. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.